Curcumin disrupts uterine leiomyosarcoma cells through AKT-mTOR pathway inhibition (Q39568211)

13 September 2017

title

Curcumin disrupts uterine leiomyosarcoma cells through AKT-mTOR pathway inhibition (English)

1 reference

13 September 2017

0 references

1 reference

7

Nobuo Yaegashi

1 reference

13 September 2017

Tze Fang Wong

1

1 reference

13 September 2017

Takashi Takeda

2

1 reference

13 September 2017

Bin Li

3

1 reference

13 September 2017

Kenji Tsuiji

4

1 reference

13 September 2017

Mari Kitamura

5

1 reference

13 September 2017

Akiko Kondo

6

1 reference

13 September 2017

language of work or name

English

0 references

publication date

29 March 2011

1 reference

full work available at URL

13 September 2017

https://api.elsevier.com/content/article/PII:S0090825811001697?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/J.YGYNO.2011.03.001

https://api.elsevier.com/content/article/PII:S0090825811001697?httpAccept=text/plain

28 November 2024

1 reference

https://api.crossref.org/works/10.1016/J.YGYNO.2011.03.001

28 November 2024

1 reference

13 September 2017

volume

122

1 reference

13 September 2017

issue

1

1 reference

13 September 2017

page(s)

141-148

1 reference

Surveillance, epidemiology, and end results analysis of 2677 cases of uterine sarcoma 1989-1999.

13 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016/J.YGYNO.2011.03.001

Incidence of lymph node and ovarian metastases in leiomyosarcoma of the uterus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YGYNO.2011.03.001

Retrospective review of 208 patients with leiomyosarcoma of the uterus: prognostic indicators, surgical management, and adjuvant therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YGYNO.2011.03.001

Phase II trial of cisplatin as first-line chemotherapy in patients with advanced or recurrent uterine sarcomas: a Gynecologic Oncology Group study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YGYNO.2011.03.001

Treatment of recurrent or advanced uterine sarcoma. A randomized trial of doxorubicin versus doxorubicin and cyclophosphamide (a phase III trial of the Gynecologic Oncology Group)

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YGYNO.2011.03.001

A randomized study of adriamycin with and without dimethyl triazenoimidazole carboxamide in advanced uterine sarcomas

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YGYNO.2011.03.001

Ifosfamide and doxorubicin in the treatment of advanced leiomyosarcomas of the uterus: a Gynecologic Oncology Group study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YGYNO.2011.03.001

Clinical management of uterine sarcomas

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YGYNO.2011.03.001

Loss of DNA copy number of 10q is associated with aggressive behavior of leiomyosarcomas: a comparative genomic hybridization study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YGYNO.2011.03.001

Dysregulation of the TSC-mTOR pathway in human disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YGYNO.2011.03.001

The AKT-mTOR pathway plays a critical role in the development of leiomyosarcomas

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YGYNO.2011.03.001

The role of herbs and spices in cancer prevention

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YGYNO.2011.03.001

Curcumin and cancer: an "old-age" disease with an "age-old" solution

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YGYNO.2011.03.001

Curcumin disrupts the Mammalian target of rapamycin-raptor complex.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YGYNO.2011.03.001

Increased AKT S473 phosphorylation after mTORC1 inhibition is rictor dependent and does not predict tumor cell response to PI3K/mTOR inhibition

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YGYNO.2011.03.001

Phosphorylation and regulation of Akt/PKB by the rictor-mTOR complex

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YGYNO.2011.03.001

Phase I clinical trial of oral curcumin: biomarkers of systemic activity and compliance

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YGYNO.2011.03.001

Prostaglandin D2 induces heme oxygenase-1 in human retinal pigment epithelial cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YGYNO.2011.03.001

Metformin is an AMP kinase-dependent growth inhibitor for breast cancer cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YGYNO.2011.03.001

Autophagy: a novel mechanism of synergistic cytotoxicity between doxorubicin and roscovitine in a sarcoma model.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YGYNO.2011.03.001

Yama/CPP32 beta, a mammalian homolog of CED-3, is a CrmA-inhibitable protease that cleaves the death substrate poly(ADP-ribose) polymerase

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YGYNO.2011.03.001

Apoptotic DNA fragmentation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YGYNO.2011.03.001

In vitro metformin anti-neoplastic activity in epithelial ovarian cancer.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YGYNO.2011.03.001

Curcumin inhibits Akt/mammalian target of rapamycin signaling through protein phosphatase-dependent mechanism

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YGYNO.2011.03.001

Bioavailability of curcumin: problems and promises

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YGYNO.2011.03.001

Influence of Piperine on the Pharmacokinetics of Curcumin in Animals and Human Volunteers

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YGYNO.2011.03.001

New structural analogues of curcumin exhibit potent growth suppressive activity in human colorectal carcinoma cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YGYNO.2011.03.001

Newly synthesized curcumin analog has improved potential to prevent colorectal carcinogenesis in vivo

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YGYNO.2011.03.001

Liposomal curcumin with and without oxaliplatin: effects on cell growth, apoptosis, and angiogenesis in colorectal cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YGYNO.2011.03.001

Curcumin enhances Apo2L/TRAIL-induced apoptosis in chemoresistant ovarian cancer cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YGYNO.2011.03.001

Induction of apoptosis in human lung cancer cells by curcumin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YGYNO.2011.03.001

Curcumin suppresses the paclitaxel-induced nuclear factor-kappaB pathway in breast cancer cells and inhibits lung metastasis of human breast cancer in nude mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YGYNO.2011.03.001

Establishment of a human leiomyosarcoma cell line

7 January 2021

18

1 reference

https://api.crossref.org/works/10.1016/J.YGYNO.2011.03.001

28 November 2024

Identifiers

1 reference

13 September 2017

1 reference